Related Experiment Videos
Time as a factor in thrombolytic therapy
1British Heart Foundation, London, UK.
International Journal of Cardiology
|August 1, 1995
Summary
Early reperfusion therapy significantly reduces mortality in myocardial infarction patients. Gaining even one hour in treatment time can decrease mortality by approximately 17%, highlighting the critical importance of prompt intervention.
Area of Science:
- Cardiovascular Medicine
- Emergency Medicine
- Clinical Trials
Background:
- Animal and human studies confirm early reperfusion limits infarct size and improves prognosis.
- Previous trials suggested a time-dependent benefit of reperfusion therapy, with greatest gains within the first hour.
Purpose of the Study:
- To evaluate the mortality benefit of early versus later reperfusion treatment in patients with myocardial infarction.
- To quantify the reduction in mortality associated with gaining treatment time.
Main Methods:
- Analysis of five randomized controlled trials comparing early versus later reperfusion therapy.
- Pooling of trial data to assess the impact of treatment delay on mortality.
Main Results:
- Randomized trials demonstrated a significant mortality benefit when reperfusion therapy was administered earlier.
- Pooled analysis indicates that achieving a 1-hour gain in treatment time reduces mortality by approximately 17%.
Conclusions:
- Early reperfusion therapy is crucial for improving outcomes in myocardial infarction.
- A significant mortality reduction is achievable by expediting treatment, emphasizing the value of time in acute cardiac events.